Change search
ReferencesLink to record
Permanent link

Direct link
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
Show others and affiliations
2004 (English)In: Ann Oncol, ISSN 0923-7534, Vol. 15, no 2, 316-323 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 15, no 2, 316-323 p.
Keyword [en]
anti-angiogenesis, cell cycle inhibitor, protein kinase C
URN: urn:nbn:se:umu:diva-15510DOI: doi:10.1093/annonc/mdh052PubMedID: 14760128OAI: diva2:155182
Available from: 2007-02-26 Created: 2007-02-26 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Henriksson, Roger
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 16 hits
ReferencesLink to record
Permanent link

Direct link